📈 Markets & Finance
Live
1 Top Wall Street Analyst Thinks This Stock Could Soar 95% Over the Next 12 Months. Here's Why I Agree.
Written by Jeff Siegel for The Motley Fool -> Additional FDA decisions could unlock new growth opportunities. Revenue is expected to nearly double this year. Profitability could finally arrive in 2
Nasdaq News — 2 August 2026
Text:
24
0
0
Additional FDA decisions could unlock new growth opportunities.
BridgeBio Pharma (NASDAQ: BBIO) has already been one of biotech's biggest winners ove
Read Full Story at Nasdaq News → Sources
📈 Markets & Finance
Indian Shares Marginally Lower In Early Trade
📈 Markets & Finance
Asian Markets Trade Mostly Higher
📈 Markets & Finance
Telix Pharmaceuticals Q2 Revenue Climbs Boosted By Precision Medicine Business
📈 Markets & Finance
Little Movement Seen For Thai Stock Market
📈 Markets & Finance
Trump finalizes new tariffs on dozens of countries
📈 Markets & Finance
Morning Minute: The Clarity Act Has New Life
